Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
36.35
+0.18 (0.50%)
At close: Mar 6, 2026, 4:00 PM EST
36.24
-0.11 (-0.29%)
After-hours: Mar 6, 2026, 7:59 PM EST
Harrow Employees
Harrow had 373 employees as of December 31, 2025. The number of employees decreased by 9 or -2.36% compared to the previous year.
Employees
373
Change (1Y)
-9
Growth (1Y)
-2.36%
Revenue / Employee
$730,035
Profits / Employee
-$13,777
Market Cap
1.35B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,379 |
| Evotec SE | 4,788 |
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,012 |
| ANI Pharmaceuticals | 970 |
| Pacira BioSciences | 790 |
HROW News
- 3 days ago - These Analysts Revise Their Forecasts On Harrow Following Q4 Results - Benzinga
- 3 days ago - Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference - GlobeNewsWire
- 3 days ago - Harrow: The Post Earnings Drop Exposes The Cost Of Growth (Rating Downgrade) - Seeking Alpha
- 3 days ago - Harrow, Inc. (HROW) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Harrow Shares Collapse, Another Opportunity? - Seeking Alpha
- 4 days ago - Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication - GlobeNewsWire
- 5 days ago - Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance - GlobeNewsWire
- 17 days ago - Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 - GlobeNewsWire